Latest News

Cancer drugs block dementia-linked brain inflammation, study finds

A class of drugs developed to treat immune-related conditions and cancer -- including one currently in clinical trials for glioblastoma and other tumors -- eliminates neural inflammation associated with dementia-linked diseases and brain injuries, according to researchers. In their study, the researchers discovered that the drugs, which can be delivered orally, eradicated microglia, the primary immune cells of the brain. These cells exacerbate many neural diseases, including Alzheimer's and Parkinson's, as well as brain injury.
View full story

Post your comment.


  • Loneliness triggers cellular changes that can cause illness, study shows

  • How cocaine changes the brain

  • Neuroscientists gain insight into cause of Alzheimer's symptoms

  • Food odors activate impulse area of the brain in obese children

  • Immune-disorder treatment in mice holds potential for multiple sclerosis patients

  • Mental health risk for new dads

  • Lactate for brain energy

  • Vision test gives insight into the effect of prenatal exposure to recreational drugs

  • Brains with autism adapt differently during implicit learning

  • Seven minutes of meditation can reduce racial prejudice, study finds